scientific programme
43
Thursday, 26 June 2014
S-34
SYMPOSIUM
09:00–11:00
Room 11
Boosting and bluntering neurocognitive
function in the laboratory and in life
Chair:
Judy Illes, Canada
S-34-001
3
Memory an the law – PTSD, Œmemory
dampening
1
and informed consent
Jennifer Chandler, Canada
S-34-002
The landscape
Judy Illes, Canada
S-34-003
DSM-5, ICD-11, RDoC, and neuroethics
Dan Stein, South Africa
S-34-004
Public attitudes towards the propriety of
cognitive enhancement
Peter Reiner, Canada
Learning Objectives:
Cognitive deficits are
among the most disabling symptoms asso-
ciated with psychiatric disorders. Those at-
tending this symposium will be made aware
of advances in treating these difficult systems.
S-35
SYMPOSIUM
09:00–11:00
Room 8+15
Track: Translational
Topic: Attention deficit disorders (D)
Adult ADHD and obesity: Neurotransmit-
ter imaging and pharmacotherapies tar-
geting impulsivity
Chair:
Ulrich Muller, United Kingdom
Co-Chair: Catharine Winstanley, Canada
S-35-001
Preclinical models of impulsivity: Pharmaco-
logical and dietary manipulations
Catharine Winstanley, Canada
S-35-002
Imaging of the dopaminergic system in
ADHD, binge eating and obesity
Gene-Jack Wang, USA
N. Volkow
S-35-003
Imaging of the noradrenergic system in
adults with obesity and ADHD
Swen Hesse, Germany
S-35-004
Pharmacological treatment of ADHD in
adults: Implications for binge eating and
obesity
Ulrich Muller, United Kingdom
Learning Objectives:
This symposium will fo-
cus on the issues of adult ADHD and obesity
and will present the delegates with findings
from neurotransmitter imaging studies and
outcomes from drug studies with a focus on
targeting impulsivity.
S-36
SYMPOSIUM
09:00–11:00
Room 10
Track: Basic
Topic: Neurodegenerative disorders, incl.
Parkinson‘s Disease; Alzheimer‘s Disease;
Huntington‘s Disease; Fronto-Temporal De-
mentia; Vascular Dementia (A)
Synaptic plasticity and neurodegeneration
Chair:
Graham Collingridge, United
Kingdom
Co-Chair: Yu Tian Wang, Canada
S-36-001
Synaptic plasticity and AD: Roles of GSK-
3beta and the JAK/STAT pathway
Graham Collingridge, United Kingdom
S-36-002
Molecular mechanisms underlying the main-
tenance of LTP and memory
Yu Tian Wang, Canada
S-36-003
Caspases in synaptic plasticity, neurodegen-
eration and cognitive function
Morgan Sheng, USA
S-36-004
Inflammation and hypoxia trigger synap-
tic depression via microglia CR3 receptors
Brian MacVicar, Canada
J. Zhang, A. Malik, H. B. Choi, R. W. Y. Ko,
L. Dissing-Olesen
Learning Objectives:
This symposium will
focus on how synaptic plasticity may be a po-
tential new treatment target for people with
neurodegenerative disorders.
